Atom Investors LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Atom Investors LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$255,706
-22.6%
190,825
+3.4%
0.06%
-53.6%
Q2 2023$330,468
-95.5%
184,619
-52.6%
0.12%
-74.0%
Q2 2020$7,383,000
-18.6%
389,807
-17.4%
0.48%
-39.6%
Q1 2020$9,071,000
+44.2%
472,182
+43.9%
0.80%
+54.8%
Q4 2019$6,290,000
+61.2%
328,118
-19.1%
0.52%
+92.9%
Q3 2019$3,902,000
+55.0%
405,617
-3.5%
0.27%
+62.8%
Q2 2019$2,518,000420,3720.16%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders